Kimber L. Poffenberger
Keine laufenden Positionen mehr
Profil
Kimber L.
Poffenberger has been Vice President of Regulatory Affairs for Iomai Corp.
since November 2005.
Most recently, she was Senior Director of Regulatory Affairs for MedImmune Vaccines, Inc. Previously, she was a Regulatory Affairs Director of Baxter BioScience Corp.
She has over 18 years of experience in the pharma and biotech field with 10 years of experience in the Food and Drug Administration.
Dr. Poffenberger received a BS degree in Biochemistry from Carnegie-Mellon University and a PhD in Microbiology from the University of Chicago.
Ehemalige bekannte Positionen von Kimber L. Poffenberger
| Unternehmen | Position | Ende |
|---|---|---|
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | - |
| IOMAI CORPORATION | General Counsel | - |
Ausbildung von Kimber L. Poffenberger
| Carnegie Mellon University | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
